Healthcare Innovation March 17, 2023
‘Culmination Bio was built to expand on the success of Intermountain’s precision medicine efforts by creating longitudinal multi-modal data sets,’ says Lincoln Nadauld, M.D., Ph.D., CEO of the new company
Utah-based Intermountain Health has launched a biotech company that it says is creating a platform of de-identified data to develop novel clinical insights, discoveries, and care processes.
Culmination Bio says its multi-modal intelligence platform provides its customers with access to omics-level data and an insights engine for medical research, health data, and healthcare services. Real-world data and evidence generation tied to the performance of diagnostics and therapeutics is a core component of the Culmination intelligence database.
Culmination launched its platform with the help of Intermountain Ventures, the strategic investment arm...
Today's Sponsors
Today's Sponsor